Home084990 • KOSDAQ
add
Helixmith Co Ltd
Nakaraang pagsara
₩2,650.00
Sakop ng araw
₩2,650.00 - ₩2,795.00
Sakop ng taon
₩2,115.00 - ₩4,950.00
Market cap
127.45B KRW
Average na Volume
98.93K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.63B | 203.14% |
Gastos sa pagpapatakbo | 2.28B | -65.70% |
Net na kita | -1.96B | 94.61% |
Net profit margin | -120.28 | 98.22% |
Kita sa bawat share | — | — |
EBITDA | -280.49M | 92.01% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 76.11B | -33.22% |
Kabuuang asset | 148.89B | -34.49% |
Kabuuang sagutin | 6.85B | -90.68% |
Kabuuang equity | 142.04B | — |
Natitirang share | 46.05M | — |
Presyo para makapag-book | 0.86 | — |
Return on assets | -2.10% | — |
Return on capital | -2.19% | — |
Cash Flow
Net change in cash
| (KRW) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.96B | 94.61% |
Cash mula sa mga operasyon | -1.39B | 68.41% |
Cash mula sa pag-invest | 1.38B | 111.33% |
Cash mula sa financing | -5.47M | -100.02% |
Net change in cash | -363.50M | -101.86% |
Malayang cash flow | -2.04B | -104.61% |
Tungkol
Helixmith Co. LTD. is a biotechnology company located in Seoul, South Korea with US presence in San Diego. The company has an extensive gene therapy pipeline, including a non-viral plasmid DNA program for neuromuscular and ischemic disease, a CAR-T program targeting several different types of solid tumors, and an AAV vector program targeting neuromuscular diseases. Helixmith’s lead gene is Engensis, currently in phase III diabetic peripheral neuropathy in the US. Engensis is a plasmid DNA designed to simultaneously express two isoforms of hepatocyte growth factor, HGF 728 and HGF 723. In addition to DPN, Engensis is also being studied in diabetic foot ulcers, amyotrophic lateral sclerosis, coronary artery disease, claudication, and Charcot-Marie-Tooth disease. Wikipedia
Itinatag
Nob 1996
Website
Mga Empleyado
72
